BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1396 related articles for article (PubMed ID: 1695478)

  • 1. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.
    Sheahan K; O'Brien MJ; Burke B; Dervan PA; O'Keane JC; Gottlieb LS; Zamcheck N
    Am J Clin Pathol; 1990 Aug; 94(2):157-64. PubMed ID: 1695478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
    Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
    Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.
    Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H
    Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies.
    Schröder S; Klöppel G
    Am J Surg Pathol; 1987 Feb; 11(2):100-8. PubMed ID: 2433953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
    Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
    Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas.
    Fowler LJ; Maygarden SJ; Novotny DB
    Hum Pathol; 1994 Jul; 25(7):666-70. PubMed ID: 8026826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
    Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
    Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.
    Robbins PF; Eggensperger D; Qi CF; Schlom J
    Int J Cancer; 1993 Apr; 53(6):892-7. PubMed ID: 8386136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
    Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
    J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.
    Primus FJ; Kuhns WJ; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):693-701. PubMed ID: 6184153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity.
    Jothy S; Brazinsky SA; Chin-A-Loy M; Haggarty A; Krantz MJ; Cheung M; Fuks A
    Lab Invest; 1986 Jan; 54(1):108-17. PubMed ID: 2417036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members.
    Thompson J; Mössinger S; Reichardt V; Engels U; Beauchemin N; Kommoss F; von Kleist S; Zimmermann W
    Int J Cancer; 1993 Sep; 55(2):311-9. PubMed ID: 7690349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
    Verstijnen CP; Arends JW; Moerkerk PT; Warnaar S; Hilgers J; Bosman FT
    Anticancer Res; 1986; 6(1):97-104. PubMed ID: 2420267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid.
    Kakudo K; Takami H; Katayama S; Matsuura N; Kamoshida S; Miyauchi A; Watanabe K
    Acta Pathol Jpn; 1990 Apr; 40(4):261-6. PubMed ID: 2371832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues.
    Wagener C; Petzold P; Köhler W; Totović V
    Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of mesothelin immunostaining in tumor diagnosis.
    Ordóñez NG
    Am J Surg Pathol; 2003 Nov; 27(11):1418-28. PubMed ID: 14576474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.
    Charpin C; Bhan AK; Zurawski VR; Scully RE
    Int J Gynecol Pathol; 1982; 1(3):231-45. PubMed ID: 6193072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.
    Bätge B; Bosslet K; Sedlacek HH; Kern HF; Klöppel G
    Virchows Arch A Pathol Anat Histopathol; 1986; 408(4):361-74. PubMed ID: 3004013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.